IMMUNE NETWORK

  • 제10권3호
  • /
  • Pages.92-98
  • /
  • 2010
  • /
  • 1598-2629(pISSN)
  • /
  • 2092-6685(eISSN)
대한면역학회 (The Korean Association of Immunobiologists)
권호 표지
DOI QR코드

DOI QR Code

Cyclooxygenase Inhibitors, Aspirin and Ibuprofen, Inhibit MHC-restricted Antigen Presentation in Dendritic Cells

  • Kim, Hyun-Jin (College of Pharmacy, Chungbuk National University) ;
  • Lee, Young-Hee (College of Pharmacy, Chungbuk National University) ;
  • Im, Sun-A (College of Pharmacy, Chungbuk National University) ;
  • Kim, Kyungjae (College of Pharmacy, SahmYook University) ;
  • Lee, Chong-Kil (College of Pharmacy, Chungbuk National University)
  • 투고 : 2010.04.21
  • 심사 : 2010.05.07
  • 발행 : 2010.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used to relieve pain, reduce fever and inhibit inflammation. NSAIDs function mainly through inhibition of cyclooxygenase (COX). Growing evidence suggests that NSAIDs also have immunomodulatory effects on T and B cells. Here we examined the effects of NSAIDs on the antigen presenting function of dendritic cells (DCs). Methods: DCs were cultured in the presence of aspirin or ibuprofen, and then allowed to phagocytose biodegradable microspheres containing ovalbumin (OVA). After washing and fixing, the efficacy of OVA peptide presentation by DCs was evaluated using OVA-specific CD8 and CD4 T cells. Results: Aspirin and ibuprofen at high concentrations inhibited both MHC class I and class II-restricted presentation of OVA in DCs. In addition, the DCs generated in the presence of low concentrations of the drugs exhibit a profoundly suppressed capability to present MHC-restricted antigens. Aspirin and ibuprofen did not inhibit the phagocytic activity of DCs, the expression level of total MHC molecules and co-stimulatory molecules on DCs. Ibuprofen rather increased the expression level of total MHC molecules and co-stimulatory molecules on DCs. Conclusion: These results demonstrate that aspirin and ibuprofen inhibit the intracellular processing event of the phagocytosed antigen, and further suggest that prolonged administration of NSAIDs in high doses may impair the capability of DCs to present antigens in asiociation with MHC molecules.

키워드

참고문헌

  1. Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231; 232-235, 1971
  2. Smith WL, DeWitt DL, Garavito RM: Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69;145-182, 2000 https://doi.org/10.1146/annurev.biochem.69.1.145
  3. Smith WL, Dewitt DL: Prostaglandin endoperoxide H synthases- 1 and -2. Adv Immunol 62;167-215, 1996 https://doi.org/10.1016/S0065-2776(08)60430-7
  4. Griswold DE, Adams JL: Constitutive cyclooxygenase (COX-1) and inducible cyclooxygenase (COX-2): rationale for selective inhibition and progress to date. Med Res Rev 16;181-206, 1996 https://doi.org/10.1002/(SICI)1098-1128(199603)16:2<181::AID-MED3>3.0.CO;2-X
  5. DeWitt DL: Cox-2-selective inhibitors: the new super aspirins. Mol Pharmacol 55;625-631, 1999
  6. Cryer B, Feldman M: Cyclooxygenase-1 and cyclooxygenase- 2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am J Med 104;413-421, 1998 https://doi.org/10.1016/S0002-9343(98)00091-6
  7. Kazmi SM, Plante RK, Visconti V, Taylor GR, Zhou L, Lau CY: Suppression of NF kappa B activation and NF kappa B-dependent gene expression by tepoxalin, a dual inhibitor of cyclooxygenase and 5-lipoxygenase. J Cell Biochem 57;299-310, 1995 https://doi.org/10.1002/jcb.240570214
  8. Hall VC, Wolf RE: Effects of tenidap and nonsteroidal antiinflammatory drugs on the response of cultured human T cells to interleukin 2 in rheumatoid arthritis. J Rheumatol 24;1467-1470, 1997
  9. Iniguez MA, Punzón C, Fresno M: Induction of cyclooxygenase- 2 on activated T lymphocytes: regulation of T cell activation by cyclooxygenase-2 inhibitors. J Immunol 163;111-119, 1999
  10. Kopp E, Ghosh S: Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 265;956-959, 1994 https://doi.org/10.1126/science.8052854
  11. Yin MJ, Yamamoto Y, Gaynor RB: The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 396;77-80, 1998 https://doi.org/10.1038/23948
  12. Jiang C, Ting AT, Seed B: PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391;82-86, 1998 https://doi.org/10.1038/34184
  13. Bancos S, Bernard MP, Topham DJ, Phipps RP: Ibuprofen and other widely used non-steroidal anti-inflammatory drugs inhibit antibody production in human cells. Cell Immunol 258;18-28, 2009 https://doi.org/10.1016/j.cellimm.2009.03.007
  14. Paccani SR, Boncristiano M, Ulivieri C, D'Elios MM, Del PG, Baldari CT: Nonsteroidal anti-inflammatory drugs suppress T-cell activation by inhibiting p38 MAPK induction. J Biol Chem 277;1509-1513, 2002 https://doi.org/10.1074/jbc.M110676200
  15. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K: Immunobiology of dendritic cells. Annu Rev Immunol 18;767-811, 2000 https://doi.org/10.1146/annurev.immunol.18.1.767
  16. Karttunen J, Sanderson S, Shastri N: Detection of rare antigen- presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens. Proc Natl Acad Sci U S A 89;6020-6024, 1992 https://doi.org/10.1073/pnas.89.13.6020
  17. Harding CV, Collins DS, Kanagawa O, Unanue ER: Liposome- encapsulated antigens engender lysosomal processing for class II MHC presentation and cytosolic processing for class I presentation. J Immunol 147;2860-2863, 1991
  18. Shen Z, Reznikoff G, Dranoff G, Rock KL: Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol 158;2723-2730, 1997
  19. Lee JK, Lee MK, Yun YP, Kim Y, Kim JS, Kim YS, Kim K, Han SS, Lee CK: Acemannan purified from Aloe vera induces phenotypic and functional maturation of immature dendritic cells. Int Immunopharmacol 1;1275-1284, 2001 https://doi.org/10.1016/S1567-5769(01)00052-2
  20. Lee YH, Lee YR, Im SA, Park SI, Kim KH, Gerelchuluun T, Song S, Kim K, Lee CK: Calcineurin inhibitors block MHC-restricted antigen presentation in vivo. J Immunol 179;5711-5716, 2007
  21. Borthwick GM, Johnson AS, Partington M, Burn J, Wilson R, Arthur HM: Therapeutic levels of aspirin and salicylate directly inhibit a model of angiogenesis through a Cox-independent mechanism. FASEB J 20;2009-2016, 2006 https://doi.org/10.1096/fj.06-5987com
  22. Blain H, Boileau C, Lapicque F, Nédélec E, Loeuille D, Guillaume C, Gaucher A, Jeandel C, Netter P, Jouzeau JY: Limitation of the in vitro whole blood assay for predicting the COX selectivity of NSAIDs in clinical use. Br J Clin Pharmacol 53;255-265, 2002 https://doi.org/10.1046/j.0306-5251.2001.01533.x
  23. Heath WR, Carbone FR: Cross-presentation, dendritic cells, tolerance and immunity. Annu Rev Immunol 19;47-64, 2001 https://doi.org/10.1146/annurev.immunol.19.1.47
  24. Huang AY, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D, Levitsky H: Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264;961-965, 1994 https://doi.org/10.1126/science.7513904
  25. Sigal LJ, Crotty S, Andino R, Rock KL: Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature 398;77-80, 1999 https://doi.org/10.1038/18038

피인용 문헌

  1. Dendritic Cells in Human Atherosclerosis: From Circulation to Atherosclerotic Plaques vol.2011, pp.None, 2010, https://doi.org/10.1155/2011/941396
  2. Anti-Inflammatory Effects of Natural Product Formulations on Murine Dendritic Cells vol.8, pp.1, 2010, https://doi.org/10.3109/19390211.2010.542233
  3. Pharmacological manipulation of dendritic cells in the pursuit of transplantation tolerance vol.16, pp.4, 2010, https://doi.org/10.1097/mot.0b013e3283484b42
  4. The Role of Anti-Inflammatory Drugs in Colorectal Cancer vol.64, pp.None, 2010, https://doi.org/10.1146/annurev-med-112211-154330
  5. Dendritic Cells in Cardiovascular Diseases : Epiphenomenon, Contributor, or Therapeutic Opportunity vol.128, pp.24, 2010, https://doi.org/10.1161/circulationaha.113.003364
  6. Authors’ response to R Pellicano and S Fagoonee vol.44, pp.1, 2015, https://doi.org/10.1093/ije/dyu217
  7. Effect of antipyretic analgesics on immune responses to vaccination vol.12, pp.9, 2010, https://doi.org/10.1080/21645515.2016.1183077
  8. Effect of Drugs on Orthodontic Tooth Movement in Human Beings: A Systematic Review of Randomized Clinical Trials vol.13, pp.None, 2010, https://doi.org/10.2174/1874210601913010022
  9. The Use of Analgesics during Vaccination with a Live Attenuated Yersinia pestis Vaccine Alters the Resulting Immune Response in Mice vol.7, pp.4, 2010, https://doi.org/10.3390/vaccines7040205
  10. A Review of Recommendations for Routine Immunization Services During COVID-19 Pandemic That are Relevant for Nursing Personnel Involved in the Implementation of Immunoprophylaxis vol.13, pp.None, 2020, https://doi.org/10.2147/jmdh.s271182
  11. COVID-19 as an Acute Inflammatory Disease vol.205, pp.1, 2010, https://doi.org/10.4049/jimmunol.2000413
  12. GRAS-microparticle microarrays identify dendritic cell tolerogenic marker-inducing formulations vol.21, pp.18, 2010, https://doi.org/10.1039/d1lc00096a
  13. Effect of prophylactic administration of antipyretics on the immune response to pneumococcal conjugate vaccines in children: a systematic review vol.13, pp.1, 2010, https://doi.org/10.1186/s41479-021-00085-8